ATE216366T1 - 2-aminobenzazepin-derivate und ihre verwendung für die behandlung von immunosuppression - Google Patents

2-aminobenzazepin-derivate und ihre verwendung für die behandlung von immunosuppression

Info

Publication number
ATE216366T1
ATE216366T1 AT97305934T AT97305934T ATE216366T1 AT E216366 T1 ATE216366 T1 AT E216366T1 AT 97305934 T AT97305934 T AT 97305934T AT 97305934 T AT97305934 T AT 97305934T AT E216366 T1 ATE216366 T1 AT E216366T1
Authority
AT
Austria
Prior art keywords
treatment
immunosuppression
aminobenzazepine
derivatives
cancer
Prior art date
Application number
AT97305934T
Other languages
English (en)
Inventor
Christopher B Cooper
Joseph P Lyssikatos
Donald W Mann
Scott J Hecker
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE216366T1 publication Critical patent/ATE216366T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT97305934T 1996-08-16 1997-08-05 2-aminobenzazepin-derivate und ihre verwendung für die behandlung von immunosuppression ATE216366T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2342396P 1996-08-16 1996-08-16

Publications (1)

Publication Number Publication Date
ATE216366T1 true ATE216366T1 (de) 2002-05-15

Family

ID=21815010

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97305934T ATE216366T1 (de) 1996-08-16 1997-08-05 2-aminobenzazepin-derivate und ihre verwendung für die behandlung von immunosuppression

Country Status (10)

Country Link
US (1) US6043238A (de)
EP (1) EP0825186B1 (de)
JP (1) JP2978850B2 (de)
AT (1) ATE216366T1 (de)
CA (1) CA2213108C (de)
DE (1) DE69711996T2 (de)
DK (1) DK0825186T3 (de)
ES (1) ES2173391T3 (de)
MX (1) MX9706231A (de)
PT (1) PT825186E (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5426500A (en) * 1999-06-16 2001-01-02 Takeda Chemical Industries Ltd. Benzazepine derivatives, process for the preparation of the same and uses thereof
SE0003795D0 (sv) 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds
TW201402124A (zh) * 2005-08-19 2014-01-16 Array Biopharma Inc 作為類鐸受體（ｔｏｌｌ-ｌｉｋｅ ｒｅｃｅｐｔｏｒ）調節劑之８-經取代苯并氮雜呯
TWI382019B (zh) * 2005-08-19 2013-01-11 Array Biopharma Inc 作為類鐸受體（ｔｏｌｌ-ｌｉｋｅ ｒｅｃｅｐｔｏｒ）調節劑之胺基二氮雜呯
WO2010014913A1 (en) 2008-08-01 2010-02-04 Ventirx Pharmaceuticals, Inc. Toll-like receptor agonist formulations and their use
ES2545275T3 (es) 2008-11-06 2015-09-09 Ventirx Pharmaceuticals, Inc. Métodos de síntesis de derivados de benzazepinas
CN105669553A (zh) 2009-08-18 2016-06-15 文蒂雷克斯药品公司 作为toll样受体调节剂的取代的苯并氮杂*
RU2016108987A (ru) * 2009-08-18 2018-11-26 Вентиркс Фармасьютикалз, Инк. Замещенные бензоазепины в качестве модуляторов toll-подобного рецептора
HUE032774T2 (en) 2010-04-21 2017-10-30 Ventirx Pharmaceuticals Inc Increase antibody-dependent cellular cytotoxicity
DK2663555T3 (en) * 2011-01-12 2017-03-27 Ventirx Pharmaceuticals Inc SUBSTITUTED BENZOAZEPINS AS MODULATORS OF TOLL-LIKE RECEPTORS
EP3208263A1 (de) * 2011-01-12 2017-08-23 VentiRx Pharmaceuticals, Inc. Substituierte benzoazepine als toll-like-rezeptor-modulatoren
CN109311854B (zh) 2016-05-23 2021-08-10 豪夫迈·罗氏有限公司 具有仲酰胺官能团的苯并氮杂卓二甲酰胺化合物
JP6918838B2 (ja) 2016-05-23 2021-08-11 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト 第三級アミド基を有するベンズアゼピンジカルボキサミド化合物
JP7012668B2 (ja) 2016-06-12 2022-02-14 エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト ジヒドロピリミジニルベンズアゼピンジカルボキサミド化合物
SG10202110182PA (en) 2017-03-15 2021-10-28 Silverback Therapeutics Inc Benzazepine compounds, conjugates, and uses thereof
JP2021506827A (ja) 2017-12-15 2021-02-22 シルバーバック セラピューティックス インコーポレイテッド 肝炎の治療用の抗体コンストラクト−薬物コンジュゲート
CN109956903B (zh) * 2017-12-22 2022-08-23 江苏恒瑞医药股份有限公司 苯并氮杂䓬衍生物、其制备方法及其在医药上的应用
KR20220035908A (ko) 2019-06-19 2022-03-22 실버백 테라퓨틱스, 인크. 항-메소텔린 항체 및 이의 면역접합체
JP7735291B2 (ja) 2020-02-21 2025-09-08 エーアールエス ファーマシューティカルズ、インコーポレイテッド ネクチン－４抗体コンジュゲートおよびその使用
JP2023532304A (ja) 2020-07-01 2023-07-27 エーアールエス ファーマシューティカルズ オペレーションズ，インク． 抗ａｓｇｒ１抗体コンジュゲートおよびその使用
US20240209080A1 (en) 2021-04-10 2024-06-27 Profoundbio Us Co. Folr1 binding agents, conjugates thereof and methods of using the same
CA3216459A1 (en) 2021-04-23 2022-10-27 Profoundbio Us Co. Anti-cd70 antibodies, conjugates thereof and methods of using the same
TW202320857A (zh) 2021-07-06 2023-06-01 美商普方生物製藥美國公司 連接子、藥物連接子及其結合物及其使用方法
WO2023088420A1 (en) * 2021-11-19 2023-05-25 Chengdu Anticancer Bioscience, Ltd. 1h-benzo[b]azepin-2(3h)-one compounds, compositions and methods of treating cancer
AR133955A1 (es) 2023-09-26 2025-11-19 Profoundbio Us Co Agentes de unión a ptk7, conjugados de éstos y métodos de uso de los mismos
WO2025149661A1 (en) 2024-01-10 2025-07-17 Genmab A/S Slitrk6 binding agents, conjugates thereof and methods of using the same
US20250381289A1 (en) 2024-02-29 2025-12-18 Genmab A/S Egfr and c-met bispecific binding agents, conjugates thereof and methods of using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3509130A (en) * 1966-12-09 1970-04-28 Ciba Geigy Corp 2-amino-1-benzazepines
US4968701A (en) * 1988-04-26 1990-11-06 E. I. Du Pont De Nemours And Company 4-Quinoline carboxylic acid derivatives useful as immunosuppressive agents
US5310913A (en) * 1989-06-09 1994-05-10 Kabi Pharmacia Aktiebolag Derivatives of quinoline-3-carboxanilide
US5268376A (en) * 1991-09-04 1993-12-07 Minnesota Mining And Manufacturing Company 1-substituted 1H-imidazo[4,5-c]quinolin-4-amines

Also Published As

Publication number Publication date
JPH1087631A (ja) 1998-04-07
DE69711996T2 (de) 2002-08-22
CA2213108A1 (en) 1998-02-16
MX9706231A (es) 1998-02-28
JP2978850B2 (ja) 1999-11-15
ES2173391T3 (es) 2002-10-16
US6043238A (en) 2000-03-28
EP0825186A1 (de) 1998-02-25
DE69711996D1 (de) 2002-05-23
PT825186E (pt) 2002-08-30
EP0825186B1 (de) 2002-04-17
CA2213108C (en) 2001-12-11
DK0825186T3 (da) 2002-07-22

Similar Documents

Publication Publication Date Title
DE69711996D1 (de) 2-Aminobenzazepin-Derivate und ihre Verwendung für die Behandlung von Immunosuppression
BG105784A (en) Triazole compounds with dopamine-d3-receptor affinity
NL300216I1 (nl) Pyranonverbindingen die bruikbaar zijn voor het behandelen van retroviarale infecties.
DE69319976D1 (de) 7-Substituierte-9-substituierte Glycylamido-6-Demethyl-6-Deoxytetracycline
TW269678B (de)
ATE215530T1 (de) 7-substituierte-8-substituierte-9-substituierte amino-7-demethyl-6-deoxy-tetracycline als antibiotische mittel
PT705833E (pt) Derivado de dc-89
TR200800474T2 (tr) Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem.
CA2096407A1 (en) Retroviral protease inhibitors
EP0711768A4 (de) Benzimidazol-derivate
GR3033397T3 (en) Novel tetrapeptide derivative.
RU94046018A (ru) 3-арилпиразольные производные, способ их получения и фунгицидная композиция на их основе
CA2188580A1 (en) N-cyanoaryl nitrogen heterocycles
RU94043771A (ru) Замещенные бензимидазольные соединения, способ лечения, фармацевтическая композиция и способ получения бензимидазольных соединений
CA2267309A1 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
RU95106653A (ru) Производные 2-имидазолин-5-онов и 2-имидазолин-5-тионов и фунгицидные композиции на их основе
ES2102772T3 (es) Compuesto citotoxico y antiviral.
AU1192397A (en) Substituted thiazolines and their use for controlling animal pests
FI103055B1 (fi) Menetelmä tiomarinolijohdannaisten valmistamiseksi
EP0551844A3 (de)
BR9611520A (pt) Composto hemo-reguladores.
ATE222255T1 (de) 14-substituierte marcfortine und derivate als antiparasitäre mittel
ATE176242T1 (de) Uck14-verbindungen
ES2159087T3 (es) Oxindoles sustituidos con adamantilo como agentes farmaceuticos.
AU6029090A (en) Improvements in or relating to organic compounds

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee